LiDCO (AIM: LID), the hemodynamic monitoring company, announces that it has been granted 510k market clearance from the US Food and Drug Administration (FDA) for its latest product, the LiDCOunity, a ...
LiDCO Group Plc (AIM: LID), the cardiovascular monitoring company, announces that approval has been obtained for reimbursement in Japan of its single patient disposable kit (which contains an Argon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results